{"id":"https://openalex.org/W4389945152","doi":"https://doi.org/10.1161/circ.148.suppl_1.13263","title":"Abstract 13263: Utilization of Proteomic Surrogates for Early Detection of Unexpected Drug Benefits","display_name":"Abstract 13263: Utilization of Proteomic Surrogates for Early Detection of Unexpected Drug Benefits","publication_year":2023,"publication_date":"2023-11-07","ids":{"openalex":"https://openalex.org/W4389945152","doi":"https://doi.org/10.1161/circ.148.suppl_1.13263"},"language":"en","primary_location":{"id":"doi:10.1161/circ.148.suppl_1.13263","doi":"https://doi.org/10.1161/circ.148.suppl_1.13263","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1161/circ.148.suppl_1.13263","pdf_url":null,"source":{"id":"https://openalex.org/S116251202","display_name":"Circulation","issn_l":"0009-7322","issn":["0009-7322","1524-4539"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5102927357","display_name":"Jessica Chadwick","orcid":"https://orcid.org/0000-0002-2017-3094","observed_orcids":["https://orcid.org/0000-0002-2017-3094"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jessica Chadwick","raw_affiliation_strings":["Bailey, CO"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bailey, CO","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055843946","display_name":"Michael Hinterberg","orcid":"https://orcid.org/0000-0003-0693-7075","observed_orcids":["https://orcid.org/0000-0003-0693-7075"]},"institutions":[{"id":"https://openalex.org/I4210098892","display_name":"SomaLogic (United States)","ror":"https://ror.org/00yvkcc48","country_code":"US","type":"company","lineage":["https://openalex.org/I4210098892"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Hinterberg","raw_affiliation_strings":["SomaLogic, Inc., Loveland, CO"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"SomaLogic, Inc., Loveland, CO","institution_ids":["https://openalex.org/I4210098892"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017493524","display_name":"Clare Paterson","orcid":"https://orcid.org/0000-0001-7454-560X","observed_orcids":["https://orcid.org/0000-0001-7454-560X"]},"institutions":[{"id":"https://openalex.org/I4210098892","display_name":"SomaLogic (United States)","ror":"https://ror.org/00yvkcc48","country_code":"US","type":"company","lineage":["https://openalex.org/I4210098892"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Clare Paterson","raw_affiliation_strings":["SomaLogic Inc, Erie, CO"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"SomaLogic Inc, Erie, CO","institution_ids":["https://openalex.org/I4210098892"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083098899","display_name":"Sama Shrestha","orcid":"https://orcid.org/0000-0003-4988-6474","observed_orcids":["https://orcid.org/0000-0003-4988-6474"]},"institutions":[{"id":"https://openalex.org/I4210098892","display_name":"SomaLogic (United States)","ror":"https://ror.org/00yvkcc48","country_code":"US","type":"company","lineage":["https://openalex.org/I4210098892"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sama Shrestha","raw_affiliation_strings":["SomaLogic, Boulder, CO"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"SomaLogic, Boulder, CO","institution_ids":["https://openalex.org/I4210098892"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038534789","display_name":"Missy Simpson","orcid":"https://orcid.org/0000-0002-9757-4427","observed_orcids":["https://orcid.org/0000-0002-9757-4427"]},"institutions":[{"id":"https://openalex.org/I4210098892","display_name":"SomaLogic (United States)","ror":"https://ror.org/00yvkcc48","country_code":"US","type":"company","lineage":["https://openalex.org/I4210098892"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Missy Simpson","raw_affiliation_strings":["Somalogic, Boulder, CO"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Somalogic, Boulder, CO","institution_ids":["https://openalex.org/I4210098892"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053906107","display_name":"Emma V. Troth","orcid":"https://orcid.org/0000-0002-5879-7695","observed_orcids":["https://orcid.org/0000-0002-5879-7695"]},"institutions":[{"id":"https://openalex.org/I4210098892","display_name":"SomaLogic (United States)","ror":"https://ror.org/00yvkcc48","country_code":"US","type":"company","lineage":["https://openalex.org/I4210098892"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Emma Troth","raw_affiliation_strings":["SomaLogic, Boulder, CO"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"SomaLogic, Boulder, CO","institution_ids":["https://openalex.org/I4210098892"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5078780592","display_name":"Stephen A. Williams","orcid":"https://orcid.org/0000-0002-8661-4315","observed_orcids":["https://orcid.org/0000-0002-8661-4315"]},"institutions":[{"id":"https://openalex.org/I4210098892","display_name":"SomaLogic (United States)","ror":"https://ror.org/00yvkcc48","country_code":"US","type":"company","lineage":["https://openalex.org/I4210098892"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stephen A Williams","raw_affiliation_strings":["SomaLogic Inc, Boulder, CO"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"SomaLogic Inc, Boulder, CO","institution_ids":["https://openalex.org/I4210098892"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"148","issue":"Suppl_1","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.6812000274658203,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.6812000274658203,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10198","display_name":"Heart Failure Treatment and Management","score":0.08340000361204147,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.027000000700354576,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.9350000023841858},{"id":"https://openalex.org/keywords/sglt2-inhibitors","display_name":"SGLT2 inhibitors","score":0.9710000157356262},{"id":"https://openalex.org/keywords/exenatide","display_name":"exenatide","score":0.9829999804496765},{"id":"https://openalex.org/keywords/empagliflozin","display_name":"empagliflozin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/cardiovascular-risk-prediction","display_name":"cardiovascular risk prediction","score":0.7960000038146973},{"id":"https://openalex.org/keywords/renal-protection","display_name":"renal protection","score":0.8330000042915344},{"id":"https://openalex.org/keywords/sample-size-reduction","display_name":"sample size reduction","score":0.5870000123977661},{"id":"https://openalex.org/keywords/power-analysis","display_name":"power analysis","score":0.5899999737739563},{"id":"https://openalex.org/keywords/plasma-proteins","display_name":"plasma proteins","score":0.44999998807907104},{"id":"https://openalex.org/keywords/drug-development-cost-reduction","display_name":"drug development cost reduction","score":0.628000020980835},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.7549999952316284}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8853956460952759},{"id":"https://openalex.org/C2780533449","wikidata":"https://www.wikidata.org/wiki/Q417762","display_name":"Exenatide","level":4,"score":0.5915275812149048},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5560591816902161},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.515842616558075},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5156065821647644},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4820290803909302},{"id":"https://openalex.org/C129848803","wikidata":"https://www.wikidata.org/wiki/Q2564360","display_name":"Sample size determination","level":2,"score":0.43140989542007446},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.42631274461746216},{"id":"https://openalex.org/C3018122547","wikidata":"https://www.wikidata.org/wiki/Q5690813","display_name":"Health benefits","level":2,"score":0.42600396275520325},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3332427442073822},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.317829966545105},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.30669069290161133},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.19436120986938477},{"id":"https://openalex.org/C556039675","wikidata":"https://www.wikidata.org/wiki/Q771035","display_name":"Traditional medicine","level":1,"score":0.0},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.0},{"id":"https://openalex.org/C105795698","wikidata":"https://www.wikidata.org/wiki/Q12483","display_name":"Statistics","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1161/circ.148.suppl_1.13263","doi":"https://doi.org/10.1161/circ.148.suppl_1.13263","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1161/circ.148.suppl_1.13263","pdf_url":null,"source":{"id":"https://openalex.org/S116251202","display_name":"Circulation","issn_l":"0009-7322","issn":["0009-7322","1524-4539"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4412063942","https://openalex.org/W4380681703","https://openalex.org/W4302011849","https://openalex.org/W7167084172","https://openalex.org/W7166435005","https://openalex.org/W4302027730","https://openalex.org/W7118953398","https://openalex.org/W7029295783","https://openalex.org/W2761933427","https://openalex.org/W2791141610"],"abstract_inverted_index":{"Introduction:":[0],"Detection":[1],"of":[2,7,21,38,53,58,82,93,105,166,197,221,242,266,281,312,318],"benefits":[3,40,97,196,280],"and":[4,19,28,56,64,72,86,115,138,150,237,284,292,310],"adverse":[5],"effects":[6,317],"therapies":[8],"in":[9,99,101,144,252,296,321],"early":[10],"clinical":[11,22],"trial":[12],"phases":[13],"could":[14,89],"improve":[15],"the":[16,48,62,163,175,194,297,308],"safety,":[17],"efficiency,":[18],"cost":[20,311],"trials.":[23,299],"For":[24],"example,":[25],"while":[26],"SGLT2i":[27,73,285],"GLP-1":[29,282],"RA":[30,283],"drugs":[31,286],"are":[32],"recognized":[33],"success":[34],"stories,":[35],"earlier":[36,98],"identification":[37],"their":[39],"beyond":[41],"improved":[42],"diabetic":[43],"control":[44,151],"may":[45,301],"have":[46,90],"had":[47],"potential":[49],"to":[50,69,132,161,169,229,260,277],"save":[51],"loss":[52],"patients\u2019":[54],"lives":[55],"years":[57,231],"sales.":[59],"Hypothesis:":[60],"Using":[61],"EXSCEL":[63],"SUGAR-DM-HF":[65,148,154],"trials":[66],"as":[67],"examples":[68],"study":[70],"GLP1-RA":[71],"responses,":[74],"we":[75],"hypothesized":[76],"that":[77,193],"previously":[78],"validated":[79],"proteomic":[80,203,250],"surrogates":[81,251],"cardiovascular":[83,195],"(CV)":[84],"events,":[85],"kidney":[87,116,234],"health":[88],"enabled":[91],"detection":[92],"these":[94],"unexpected":[95],"drug":[96,313],"development":[100,314],"a":[102,108,171,185,202,212,288,303],"smaller":[103],"number":[104,165],"participants":[106,226,267,294],"over":[107],"shorter":[109,323],"follow-up":[110],"period.":[111],"Methods:":[112],"CV":[113,238],"risk":[114],"prognosis":[117],"SomaSignal":[118,273],"tests":[119,274],"(each":[120],"derived":[121],"from":[122],"~5000":[123],"plasma":[124,134],"proteins":[125],"measurements":[126],"using":[127,184,249],"SomaScan\u00ae":[128],"assay)":[129],"were":[130,159,199,247,275],"applied":[131],"paired":[133],"samples":[135,167],"at":[136],"baseline":[137],"9-months":[139],"(SUGAR-DM-HF)":[140],"or":[141],"1-year":[142,206,214],"(EXSCEL)":[143],"intervention":[145],"(EXSCEL":[146,152],"n=1840;":[147],"n=45)":[149],"n=1833;":[153],"n=52)":[155],"participants.":[156],"Power":[157],"calculations":[158],"performed":[160],"determine":[162],"minimum":[164],"needed":[168],"detect":[170],"significant":[172,213],"change":[173,215],"within":[174,205,244,287],"treatment":[176],"period":[177],"with":[178,201,208,218,224],"alpha":[179],"=":[180],"0.05,":[181],"80%":[182],"power":[183,209],"t-test":[186],"comparing":[187],"two-sample":[188],"means.":[189],"Results:":[190],"We":[191],"demonstrated":[192],"exenatide":[198],"detectable":[200,248],"surrogate":[204],"(p=0.002),":[207],"analysis":[210],"indicating":[211],"is":[216],"observable":[217],"group":[219],"sizes":[220,255],"n=1368":[222],"compared":[223,259],">7000":[225],"for":[227,269,306],"up":[228],"6.8":[230],"follow-up.":[232],"Additionally,":[233],"protection":[235,239],"(p=0.037)":[236],"(p=0.06)":[240],"impacts":[241],"empagliflozin":[243],"36":[245],"weeks":[246],"small":[253],"sample":[254],"(n":[256],"~":[257],"50)":[258],"published":[261],"outcomes":[262],"studies":[263],"requiring":[264],"thousands":[265],"followed":[268],">2":[270],"years.":[271],"Conclusions:":[272],"able":[276],"predict":[278],"cardiometabolic":[279],"significantly":[289],"shortened":[290],"interval":[291],"fewer":[293],"than":[295],"outcome":[298],"Proteomics":[300],"provide":[302],"powerful":[304],"tool":[305],"improving":[307],"efficacy,":[309],"by":[315],"predicting":[316],"novel":[319],"therapeutics":[320],"smaller,":[322],"studies.":[324]},"counts_by_year":[],"updated_date":"2026-08-21T09:56:20.448147","created_date":"2023-12-20T00:00:00"}